Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,310,879
-$1,854,218 QoQ
Shares Held
34,252
-6.8% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#187
of 784 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GROUPAMA ASSET MANAGMENT holds $277,486,304 across 10 Biotechnology names. ALNY ranks #6 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
188,156 | $93,462,729 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
937,083 | $74,301,311 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
77,940 | $48,598,707 | |
| 4 | BNTX |
BioNTech SE
|
184,775 | $17,193,313 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
30,941 | $16,613,769 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
34,252 | $10,310,879 | |
| 7 | INCY |
Incyte Corp
|
86,423 | $9,796,911 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
229,939 | $5,914,031 |
All Filings in ALNY
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,310,879 | 34,252 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,165,097 | 36,767 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $14,266,886 | 35,878 | Shares | Sole | 2026-02-27 | |
| 2025-09-30 | $3,980,280 | 4,000,000 | Principal | Sole | 2025-12-01 | |
| 2025-09-30 | $14,629,392 | 32,082 | Shares | Sole | 2025-12-01 | |
| 2025-06-30 | $1,942,308 | 1,500,000 | Principal | Sole | 2025-08-13 | |
| 2025-06-30 | $15,777,864 | 48,385 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $10,838,332 | 40,139 | Shares | Sole | 2025-05-14 | |
| 2025-03-31 | $1,732,147 | 1,500,000 | Principal | Sole | 2025-05-14 | |
| 2024-12-31 | $6,694,569 | 28,450 | Shares | Sole | 2025-02-12 | |
| 2024-12-31 | $1,608,359 | 1,500,000 | Principal | Sole | 2025-02-12 | |
| 2024-09-30 | $1,409,146 | 1,500,000 | Principal | Sole | 2024-11-15 | |
| 2024-09-30 | $5,881,516 | 21,385 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $5,888,862 | 24,234 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $337,159 | 2,256 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,314,646 | 17,317 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||